| Followers | 1443 |
| Posts | 30453 |
| Boards Moderated | 32 |
| Alias Born | 12/10/2012 |
Friday, September 10, 2021 9:00:21 AM
$NAUT: This Amazon stake in $NAUT.........
Shouldn't be forgotten anytime soon.
If $NAUT breaks below $7, I load bigggggggggggggg
Currently at $7.50
GO $NAUT
Shouldn't be forgotten anytime soon.
If $NAUT breaks below $7, I load bigggggggggggggg
Currently at $7.50
GO $NAUT
Recent NAUT News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:10:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:10:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:09:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 08:07:50 PM
- Nautilus Biotechnology Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 04/28/2026 12:00:00 PM
- Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference • GlobeNewswire Inc. • 03/24/2026 12:00:00 PM
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform • GlobeNewswire Inc. • 03/18/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 10:31:07 PM
- Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference • GlobeNewswire Inc. • 02/19/2026 09:05:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease • GlobeNewswire Inc. • 01/28/2026 01:00:00 PM
- Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/11/2025 02:29:14 AM
- Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:11:59 PM
- Nautilus Biotechnology Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/28/2025 12:00:00 PM
- Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 • GlobeNewswire Inc. • 10/07/2025 12:00:00 PM
